IP Library Granted Patent US 8,828,458
Granted Patent B2
US 8,828,458 · App. 13/226,834 · Granted Sep 9, 2014

Topical macqui berry formulation

Inventor: Marius Morariu (Brooklyn, NY)
A61K8/97A61Q19/08A61K36/185A61K8/4913A61K8/44A61K2800/522A61K8/46A61K8/602
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,828,458
App. No.
13/226,834
Granted
Sep 9, 2014
Kind
B2
Abstract

The present invention provides a topical formulation and method of use where the formulation comprises macqui berry or a macqui berry extract containing anthocyanins having a very high oxygen radical absorbance capacity (ORAC). The formulation provides the macqui berry in a stabilized form which includes a glucuronide or glycuronide, a photostabilizing agent, encapsulation, or light- and/or air-blocking packaging.

Claims (16)

1. A topical formulation comprising: macqui berry, a macqui berry extract or a dermatologically acceptable salt thereof containing an effective amount of one or more antioxidants, and a stabilizer selected from a glucuronide, a glycuronide, or diethylhexyl syringylidene malonate.

2. The formulation claim 1 , which comprises a macqui berry, macqui berry extract, in an amount of from about 0.05 to 50% by weight, based on the total weight of the formulation.

3. The formulation claim 2 , which comprises a macqui berry, macqui berry extract, in an amount from about 1.0 to 5.0% by weight, based on the total weight of the formulation.

4. The formulation claim 1 , further comprising an additional agent.

5. The formulation of claim 4 , wherein the additional agent is an antioxidant.

6. The formulation of claim 5 , wherein the additional antioxidant s an antioxidant endogenous to the human body.

7. The formulation claim 5 , wherein the additional antioxidant is selected from the group consisting of grape seed procyanidins, tocopherols, tocotrienols, astaxanthin, lutein, lycopene, phytofluene, phytoene, rubixan thin, beta-cryptoxanthin, zeaxanthin, tumeric extract, bilberry anthocyanins, betacyanins, a purified single anthocyanin or combination of selected purified individual anthocyanins, black raspberry extract, blueberry anthocyanins, acai extract, aronia extract, prune extract, pomegranate extract, ellagic acid, honokiol, magnolol, silymarin, quercetin, naringenin, rosmarinic acid, rosemary extract, saffron extract, clove essential oil, wolfberry extract, noni fruit extract, phyllantus emblica extract, camellia sinensis extract, epicatechin-gallate, Garcinia mangostana extract, shikimic acid, montrnorency cherry extract, anthocyanin-containing extracts of red, blue, magenta, purple or black flowers, whole coffee fruit extract, chlorogenic acid, caffeic acid, ferulic acid, olive extract, and hydroxytyrosol.

8. The formulation of claim 7 , wherein the formulation comprises a metal chelating agent.

9. The formulation of claim 5 , wherein the antioxidant is formulated in a ratio with the macqui berry or macqui berry extract wherein the ORAC value is optimized.

10. The formulation claim 5 , wherein the additional antioxidant is a betacyanin.

11. The formulation of claim 5 , wherein the antioxidants are present in the same enantiomeric ratio as found for these substances in their natural form.

12. The formulation claim 1 , further comprising an AGE inhibitor, a collagen enhancing agent, a mitochondrial resuscitant, a sunscreen agent, an anti-edemic agent, a glutathione or an inducers thereof, a collagenase-inhibitor, an anti-inflammatory agent, a phenylpropanoid glycoside, a depigmenting agent or agent addressing hyperpigmentation, a skin-protective lipids, hyaluronic acid, an alpha hydroxy acid, an agent useful for treating hormonal decline, an anti-acne agent, an agent altering lipolytic activity, an anti-cellulitic agent, an agent altering anti-capillary-fragility, an anti-elastase agent, an anti-erythema agent, an agent that raises cyclic AMP, or nicotinamide-adenine-dinucleotide.

13. The formulation claim 1 , wherein the macqui berry or macqui berry extract is formulated in a makeup.

14. The formulation claim 13 , wherein the makeup is a foundation, a cover cream, or an eye shadow.

15. The topical formulation of claim 1 , wherein said formulation is a dye for cosmetic composition.

16. A formulation comprising: macqui berry, a macqui berry extract or salt thereof containing an effective amount of one or more antioxidants, and a stabilizer selected from a glucuronide, a glycuronide, or diethylhexyl syringylidene malonate, wherein the formulation is formulated for use in a beverage or in a candle.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2018
From: MORARIU, MARIUS
To: TRACIE MARTYN INTERNATIONAL, LLC
Reel/Frame 044732/0298 →
Continuity (3)
Continuation 11525288 · Sep 21, 2006
Provisional Application 60719530 · Sep 21, 2005
Related Publication 20120114719A1 · May 10, 2012